Back to Journals » Journal of Hepatocellular Carcinoma » Volume 10

Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab or Lenvatinib for Unresectable Hepatocellular Carcinoma: A Propensity Score Matched Study

Total article views   HTML views PDF downloads Totals
2,956 Dovepress* 2,415+ 68 2,483
PubMed Central* 541 460 1,001
Totals 2,956 528 3,484
*Since 25 July 2023

View citations on PubMed Central and Google Scholar